Cargando…
Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them
BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Hea...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236183/ https://www.ncbi.nlm.nih.gov/pubmed/32429909 http://dx.doi.org/10.1186/s12872-020-01523-z |
_version_ | 1783536111068381184 |
---|---|
author | Jiao, Yundi Sun, Zhaoqing Xie, Yanxia Zheng, Jia Li, Zhao Guo, Xiaofan Dai, Yue Zheng, Liqiang Sun, Yingxian |
author_facet | Jiao, Yundi Sun, Zhaoqing Xie, Yanxia Zheng, Jia Li, Zhao Guo, Xiaofan Dai, Yue Zheng, Liqiang Sun, Yingxian |
author_sort | Jiao, Yundi |
collection | PubMed |
description | BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. METHODS: We used 2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥18 years with complete blood pressure (BP) values were selected for the present analysis. RESULTS: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2 to 58.9%) and 25.4% (24.7 to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5 and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. CONCLUSIONS: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults. |
format | Online Article Text |
id | pubmed-7236183 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-72361832020-05-27 Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them Jiao, Yundi Sun, Zhaoqing Xie, Yanxia Zheng, Jia Li, Zhao Guo, Xiaofan Dai, Yue Zheng, Liqiang Sun, Yingxian BMC Cardiovasc Disord Research Article BACKGROUND: The current analysis was performed to estimate the percentage and number of Chinese adults with hypertension and the percentage and number of Chinese adults recommended to receive pharmacological antihypertensive treatment according to the 2017 American College of Cardiology/American Heart Association (ACC/AHA) guideline compared with the same parameters according to the 2010 Chinese guideline. METHODS: We used 2011 data from the China Health and Nutrition Survey (CHNS). A total of 12,499 Chinese adults aged ≥18 years with complete blood pressure (BP) values were selected for the present analysis. RESULTS: The crude prevalence rates (95% CI) of hypertension according to the definitions from the 2017 ACC/AHA guideline and the 2010 Chinese guideline were 58.0% (57.2 to 58.9%) and 25.4% (24.7 to 26.2%), respectively. Moreover, the percentage of the participants recommended to take antihypertensive medications were 31.5 and 28.8%, respectively. Among adults who took antihypertensive medications, 88.8% had above-goal BP levels compared to 53.3%. Overall, 613.3 million Chinese adults (aged ≥18 years) met the criteria for hypertension according to the 2017 ACC/AHA guideline, and 267.7 million met the criteria according to 2010 Chinese guideline. An additional 28.4 million (2.7%) Chinese adults were recommended to take antihypertensive medication. CONCLUSIONS: The present analysis revealed that the 2017 ACC/AHA hypertension guideline will result in a substantial increase in the percentage and number of Chinese adults defined as having hypertension and a small increase in the percentage of adults who are recommended to take antihypertensive medications compared to the same parameters based on the 2010 Chinese guideline. More intensive management and antihypertensive medications use are suggested to improve the control rate of hypertension among Chinese adults. BioMed Central 2020-05-19 /pmc/articles/PMC7236183/ /pubmed/32429909 http://dx.doi.org/10.1186/s12872-020-01523-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Jiao, Yundi Sun, Zhaoqing Xie, Yanxia Zheng, Jia Li, Zhao Guo, Xiaofan Dai, Yue Zheng, Liqiang Sun, Yingxian Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title | Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title_full | Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title_fullStr | Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title_full_unstemmed | Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title_short | Potential impacts of the 2017 American College of Cardiology/American Heart Association high blood pressure guideline on Chinese adults and how to address them |
title_sort | potential impacts of the 2017 american college of cardiology/american heart association high blood pressure guideline on chinese adults and how to address them |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236183/ https://www.ncbi.nlm.nih.gov/pubmed/32429909 http://dx.doi.org/10.1186/s12872-020-01523-z |
work_keys_str_mv | AT jiaoyundi potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT sunzhaoqing potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT xieyanxia potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT zhengjia potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT lizhao potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT guoxiaofan potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT daiyue potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT zhengliqiang potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem AT sunyingxian potentialimpactsofthe2017americancollegeofcardiologyamericanheartassociationhighbloodpressureguidelineonchineseadultsandhowtoaddressthem |